AccuBeing, LLC

DRASC

Medical testing for diagnostic or treatment purposes; Providing cancer screening services; Genetic counseling; Genetic testing for medical purposes; Health care services for treating cancer; Medical analysis services for the diagnosis of cancer; Providing personalized healthcare and medical information in the nature of providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate treatment for patients through the use of data obtained through personalized pharmacogenetics, genomics, proteomics and other biological testing, individual behaviors including medication compliance, exercise, diet, sleep patterns and language, epigenetic and environmental factors, and bioinformatics analysis;Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Medical and scientific research in the field of cancer treatment and diagnosis; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Software as a service (SAAS) services featuring software for precision oncology drug library screening; Product research and development, namely, testing of the newest drugs through high-throughput smart-screening platform to determine the best pharmacological treatments for an individual patient; Pharmacological product research consultation services that will enable others, namely, doctors and clinicians, to select and recommend the appropriate treatment for patients through the use of data obtained through personalized pharmacogenetics, genomics, proteomics and other biological testing;

ROTA

Medical services; Clinical and medical laboratory testing services and information for diagnostic purposes in the fields of disease diagnostics and personalized medicine; Consulting services in the field of genetic testing for medical purposes; Consulting services in the field of medical testing for diagnostic purposes; Medical analysis services of patient medical data for the treatment of cancer; Medical services in the field of oncology; Providing personalized drug therapy services for cancer patients; Growing cancer cells in tissue culture and assessing the cells for diagnostic and prognostic purposes; laboratory testing services for medical diagnostic or treatment purposes;Medical and scientific research services in the areas of cancer and other diseases; Providing medical and scientific research information, consultancy, and advisory services, all in the fields of treatment of cancer; Laboratory research services relating to pharmaceuticals; Pharmaceutical research in the field of oncology; Oncology research; Research and development in the biotechnology and oncology fields; Drug testing and discovery services in the field of oncology; product safety testing; Technological research and development relating to the chemical and pharmaceutical industry in the field of oncology; Pharmaceutical product evaluation in the field of cancer treatment drugs; Research and development in the field of personalized medicine and its delivery to patients; Research and development of personalized cancer treatments; Scientific research, development, engineering, testing, and analytical services in the fields of medicine, pharmaceuticals, genetics, and oncology; Biological research, namely, biological sample characterization, screening, and analysis services for scientific research purposes; medical and scientific research in the fields of diseases and diagnosing and treating diseases; Providing medical testing services in the field of cancer research and disease classification; Laboratory testing services, namely, conducting medical tests on biological samples for scientific research purposes; Compiling data for medical and scientific research, clinical trials, and drug admission;